The pharmaceutical industry and profit motives underlying the opioid crisis

Via The Globe and Mail How a little-known patent sparked Canada’s opioid crisis The untold story of how a single pill sparked Canada’s opioid crisis, and ignited one of the biggest pharmaceutical battles in Canadian history By Grant Robertson AND Karen Howlett http://www.theglobeandmail.com/news/investigations/oxycontin/article33448409/

Advertisements

Critical Analysis: Valeant Pharmaceuticals Exposed

Valeant Pharmaceuticals International Inc., located in Quebec have been under tremendous public and scrutiny since hiking the prices of two lifesaving medications. These medications are Isuprel or Isoprenaline and Nitropress (CBC, 2015). Valeant purchased the rights to these two medication in February of 2015 from Marathon Pharmaceuticals. It was not until Valeant got its hands …

Continue reading Critical Analysis: Valeant Pharmaceuticals Exposed

Valeant Pharmaceuticals Exposed

Valeant Pharmaceuticals International Inc., located in Quebec, has currently been under fire since the news broke about their drug price hikes to two lifesaving heart medications: Isuprel or Isoprenaline and Nitropress. However, Marathon Pharmaceuticals held the rights of these medications before Valeant, under Marathon Pharmaceuticals there were gradual increases in price over the past three …

Continue reading Valeant Pharmaceuticals Exposed